We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$518B
AUM Growth
+$18.2B
Cap. Flow
-$36B
Cap. Flow %
-6.94%
Top 10 Hldgs %
29.96%
Holding
15,912
New
1,749
Increased
6,361
Reduced
6,148
Closed
1,439

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.78B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$973M
3
DIS icon
Walt Disney
DIS
+$588M
4
LLY icon
Eli Lilly
LLY
+$569M
5
T icon
AT&T
T
+$529M

Sector Composition

Rank Sector Weight
1 Technology 3.4%
2 Healthcare 3.08%
3 Financials 2.41%
4 Consumer Discretionary 2.33%
5 Industrials 1.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FPH icon
13251
CALL
Five Point Holdings
FPH
$371M
$12.8K ﹤0.01%
4,100
-400
-9% -$1.26K
IMMP
13252
CALL
Immutep
IMMP
$56M
$12.8K ﹤0.01%
5,500
+3,500
+175% +$8.29K
PMCB icon
13253
CALL
PharmaCyte Biotech
PMCB
$5.92M
$12.8K ﹤0.01%
5,400
-2,800
-34% -$6.06K
PRTS icon
13254
PUT
CarParts.com
PRTS
$47.1M
$12.8K ﹤0.01%
790
+550
+229% +$13.8K
ANIX icon
13255
PUT
Anixa Biosciences
ANIX
$108M
$12.8K ﹤0.01%
4,100
-16,600
-80% -$66.2K
QUBT icon
13256
CALL
Quantum Computing Inc
QUBT
$2.04B
$12.8K ﹤0.01%
+12,900
New +$11.6K
ATRA icon
13257
CALL
Atara Biotherapeutics
ATRA
$72.9M
$12.8K ﹤0.01%
736
+356
+94% +$6.32K
CSBR icon
13258
CALL
Champions Oncology
CSBR
$70.4M
$12.7K ﹤0.01%
2,600
+1,900
+271% +$11.1K
PLX icon
13259
PUT
Protalix BioTherapeutics
PLX
$179M
$12.7K ﹤0.01%
10,100
-13,900
-58% -$20.8K
ICAD
13260
PUT
DELISTED
iCAD Inc
ICAD
$12.7K ﹤0.01%
7,900
-200
-2% -$317
RPTX
13261
PUT
DELISTED
Repare Therapeutics
RPTX
$12.7K ﹤0.01%
2,700
-7,500
-74% -$48K
LGO
13262
CALL
Largo
LGO
$74.1M
$12.7K ﹤0.01%
7,700
+900
+13% +$1.76K
TNGX icon
13263
PUT
Tango Therapeutics
TNGX
$4.32B
$12.7K ﹤0.01%
+1,600
New +$17.1K
SBCF icon
13264
CALL
Seacoast Banking Corp of Florida
SBCF
$3.5B
$12.7K ﹤0.01%
+500
New +$12.6K
VBIV
13265
CALL
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$12.7K ﹤0.01%
21,000
+16,260
+343% +$9.97K
OXBR icon
13266
Oxbridge Re Holdings
OXBR
$12.4M
$12.6K ﹤0.01%
11,922
+198
+2% +$202
MIMO
13267
DELISTED
Airspan Networks Holdings Inc
MIMO
$12.6K ﹤0.01%
+111,700
New +$15.8K
IYJ icon
13268
PUT
iShares US Industrials ETF
IYJ
$1.97B
$12.6K ﹤0.01%
100
-1,300
-93% -$154K
PSNY icon
13269
Polestar Automotive Holding UK
PSNY
$2.06B
$12.6K ﹤0.01%
272
+225
+479% +$12.2K
TBPH icon
13270
CALL
Theravance Biopharma
TBPH
$881M
$12.6K ﹤0.01%
1,400
-3,100
-69% -$28.7K
ACTG icon
13271
Acacia Research
ACTG
$448M
$12.5K ﹤0.01%
2,342
-52,598
-96% -$219K
IRD
13272
PUT
Opus Genetics
IRD
$300M
$12.5K ﹤0.01%
6,200
+4,200
+210% +$10.7K
RNGR icon
13273
PUT
Ranger Energy Services
RNGR
$407M
$12.4K ﹤0.01%
+1,100
New +$11.5K
KMPR icon
13274
PUT
Kemper
KMPR
$1.62B
$12.4K ﹤0.01%
200
-2,600
-93% -$149K
TUSK icon
13275
PUT
Mammoth Energy Services
TUSK
$160M
$12.4K ﹤0.01%
3,400
-4,500
-57% -$17K

Similar funds

Citadel Advisors's Q1 2024 Portfolio in Review

As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.

By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.

  • Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
  • Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
  • Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
  • Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
  • Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
  • Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
  • Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.

Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.